Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 janv. 2016 09h00 HE | Source: Stereotaxis, Inc.

Stereotaxis Initiates Multi-Center Randomized Superiority Study on Ventricular Tachycardia Ablation Outcomes

ST. LOUIS, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that it has...
17 nov. 2015 09h00 HE | Source: Stereotaxis, Inc.

Multicenter Study Reveals Improved Long-Term Success Rates With Stereotaxis Technology in Ventricular Tachycardia

ST. LOUIS, Nov. 17, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the results of an...
03 nov. 2015 16h05 HE | Source: Stereotaxis, Inc.

Stereotaxis Reports 2015 Third Quarter Financial Results

-Total Quarterly Revenue Increased 5% Year over Year on Improved System and Recurring Revenues- -Total Revenue for First Nine Months Increased 13% Year over Year to $28.5...
27 oct. 2015 16h05 HE | Source: Stereotaxis, Inc.

Stereotaxis to Report Third Quarter 2015 Financial Results on November 3, 2015

ST. LOUIS, Oct. 27, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that it will...
12 oct. 2015 09h00 HE | Source: Stereotaxis, Inc.

Stereotaxis Introduces Respiratory Compensation Feature for Remote Magnetic Navigation Procedures

ST. LOUIS, Oct. 12, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the worldwide...
08 oct. 2015 09h00 HE | Source: Stereotaxis, Inc.

Stereotaxis Announces Results of Warrants Offering

ST. LOUIS, Oct. 08, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (“Stereotaxis”) (NASDAQ:STXS) a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced...
28 sept. 2015 09h00 HE | Source: Stereotaxis, Inc.

Stereotaxis Extends Warrants Offering Subscription Period

ST. LOUIS, Sept. 28, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced it is extending its...
23 sept. 2015 09h00 HE | Source: Stereotaxis, Inc.

Stereotaxis Launches Vmotion Suite of Automation Features in U.S. Following FDA Clearance

ST. LOUIS, Sept. 23, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the first procedures...
21 sept. 2015 09h00 HE | Source: Stereotaxis, Inc.

U.S. Physician Surpasses 1,000 Procedures Using Stereotaxis Niobe(R) System

ST. LOUIS, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced that J. David...
15 sept. 2015 07h30 HE | Source: Stereotaxis, Inc.

Stereotaxis Announces Ex-Warrants Date of September 15, 2015 for Warrants Offering

ST. LOUIS, Sept. 15, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ:STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias, announced today that the NASDAQ...

Page précédente